Reply to F.D. Leonard

J Clin Oncol. 2019 Oct 10;37(29):2701-2702. doi: 10.1200/JCO.19.01708. Epub 2019 Aug 19.

Authors

Mark Bustoros¹, Romanos Sklavenitis-Pistofidis¹, Jorge J Castillo¹, Steven P Treon¹, Irene M Ghobrial¹

Affiliation

¹ Mark Bustoros, MD; Romanos Sklavenitis-Pistofidis, MD; Jorge J. Castillo, MD; Steven P. Treon, MD, PhD; and Irene M. Ghobrial, MD, Dana-Farber Cancer Institute, Boston, MA.

PMID: 31424980
DOI: 10.1200/JCO.19.01708

No abstract available

Publication types

Comment

MeSH terms

Disease Progression
Humans
Risk Assessment
Waldenstrom Macroglobulinemia*